Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

115.42 -4.92 (-4.09%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,284,638
Open	120.63
Bid (Size)	117.10 (300)
Ask (Size)	118.10 (100)
Prev. Close	120.34
Today's Range	115.01 - 123.00
52wk Range	4.770 - 148.83
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates

Today 16:05 EDT

From Abivax

Via GlobeNewswire

Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity

Today 12:01 EDT

As the first quarter of 2026 comes to a close, the financial world is buzzing with a renewed sense of optimism. Goldman Sachs (NYSE: GS) has released its highly anticipated 2026 Global M&A Outlook,...

Via MarketMinute

Performance

YTD	-13.7%	-13.7%
1 Month	-11.5%	-11.5%
3 Month	-16.8%	-16.8%
6 Month	+40.4%	+40.4%
1 Year	+1466.1%	+1466.1%

More News

2 Healthcare Stocks to Buy Before They Get Bought Out ↗

March 20, 2026

Via The Motley Fool

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗

March 16, 2026

Via The Motley Fool

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗

March 16, 2026

Via The Motley Fool

This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? ↗

March 16, 2026

Via The Motley Fool

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗

March 16, 2026

Via The Motley Fool

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗

March 16, 2026

Via The Motley Fool

This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter ↗

March 16, 2026

Via The Motley Fool

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Via The Motley Fool

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗

March 16, 2026

Via The Motley Fool

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Via The Motley Fool

This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗

March 16, 2026

Via The Motley Fool

Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year ↗

March 10, 2026

Via The Motley Fool

2 Reasons Abivax Stock Could 10X by 2036 ↗

February 27, 2026

Via The Motley Fool

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

February 21, 2026

From Abivax

Via GlobeNewswire

Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗

February 17, 2026

Via The Motley Fool

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗

February 17, 2026

Via The Motley Fool

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗

February 14, 2026

Via The Motley Fool

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗

February 14, 2026

Via The Motley Fool

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

February 10, 2026

Via The Motley Fool

Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗

January 30, 2026

Via The Motley Fool

Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗

January 19, 2026

Via The Motley Fool

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?

Yes, Abivax SA - American Depositary Shares is publicly traded.

What exchange does Abivax SA - American Depositary Shares trade on?

Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Abivax SA - American Depositary Shares?

The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market

What is the current price of Abivax SA - American Depositary Shares?

The current price of Abivax SA - American Depositary Shares is 115.42

When was Abivax SA - American Depositary Shares last traded?

The last trade of Abivax SA - American Depositary Shares was at 03/23/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.